Sandoz is a Novartis company with a reputation for quality going back to the 19th century. Present in 130 countries, our broad portfolio of affordable, high-quality medicines is available to 90% of the world’s population.

Sandoz Biopharmaceuticals, a specialized business unit, develops, produces and markets biopharmaceutical medicines and active ingredients worldwide, and enjoys close synergies with other Novartis divisions across the value chain.

Our decades of experience and significant investments have helped to position us as the pioneer and world leader in biosimilars.

Our vision is to dramatically increase patient access to essential high-quality biopharmaceuticals, by consistently advancing this global leadership position.

Sandoz Biopharmaceuticals

Sandoz International GmbH

Industriestrasse 25

83607 Holzkirchen

Germany

Phone: +49 (0) 8024 476-0

www.sandoz-biosimilars.com